Literature DB >> 16297738

Prosthetic joint infections.

Irene G Sia1, Elie F Berbari, Adolf W Karchmer.   

Abstract

Success in the treatment of infected orthopedic prosthesis requires the best surgical approach in combination with prolonged optimum targeted antimicrobial therapy. In choosing the surgical option, one must consider the type of infection, condition of the bone stock and soft tissue, the virulence and antimicrobial susceptibility of the pathogen, the general health and projected longevity of the patient, and the experience of the surgeon. If surgery is not possible, an alternative is long-term oral antimicrobial suppression to maintain a functioning prosthesis. Treatment must be individualized for a specific infection in a specific patient.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16297738     DOI: 10.1016/j.idc.2005.07.010

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  38 in total

1.  Prior use of antimicrobial therapy is a risk factor for culture-negative prosthetic joint infection.

Authors:  Davud Malekzadeh; Douglas R Osmon; Brian D Lahr; Arlen D Hanssen; Elie F Berbari
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

2.  Prosthetic joint infection caused by Mycobacterium alvei in an elderly patient.

Authors:  Chen-Hsiang Lee; Huey-Ling You; Jun-Wen Wang; Ya-Fen Tang; Jien-Wei Liu
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

Review 3.  Prosthetic Joint Infections: an Update.

Authors:  C L Abad; A Haleem
Journal:  Curr Infect Dis Rep       Date:  2018-05-22       Impact factor: 3.725

4.  Two-Stage Total Knee Arthroplasty for Prosthetic Joint Infection.

Authors:  Min Seok Cha; Se Hyun Cho; Dong Hee Kim; Hong Kwon Yoon; Ho Seung Cho; Dong Yeong Lee; Sang Hyuk Lee; Sun Chul Hwang
Journal:  Knee Surg Relat Res       Date:  2015-06-01

5.  Successful Treatment of Prosthetic Joint Infection due to Vancomycin-resistant Enterococci with Tedizolid.

Authors:  Sheng Si; Michael J Durkin; Maureen M Mercier; Melanie L Yarbrough; Stephen Y Liang
Journal:  Infect Dis Clin Pract (Baltim Md)       Date:  2017-03

6.  Comparable outcome of culture-negative and culture-positive periprosthetic hip joint infection for patients undergoing two-stage revision.

Authors:  Jin Wang; Qiaojie Wang; Hao Shen; Xianlong Zhang
Journal:  Int Orthop       Date:  2018-02-03       Impact factor: 3.075

7.  Clinical spectrum and outcome of critically ill patients suffering from prosthetic joint infections.

Authors:  Y Maaloum; A Meybeck; D Olive; N Boussekey; P-Y Delannoy; A Chiche; H Georges; E Beltrand; E Senneville; T d'Escrivan; O Leroy
Journal:  Infection       Date:  2012-10-25       Impact factor: 3.553

Review 8.  Candida albicans prosthetic hip infection in elderly patients: is fluconazole monotherapy an option?

Authors:  Theodoros Kelesidis; Sotirios Tsiodras
Journal:  Scand J Infect Dis       Date:  2010

9.  Randomized controlled trial of the safety and efficacy of Daptomycin versus standard-of-care therapy for management of patients with osteomyelitis associated with prosthetic devices undergoing two-stage revision arthroplasty.

Authors:  Ivor Byren; Shruta Rege; Ed Campanaro; Sara Yankelev; Diane Anastasiou; Gennady Kuropatkin; Richard Evans
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

10.  Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)).

Authors:  K Reinhart; F M Brunkhorst; H-G Bone; J Bardutzky; C-E Dempfle; H Forst; P Gastmeier; H Gerlach; M Gründling; S John; W Kern; G Kreymann; W Krüger; P Kujath; G Marggraf; J Martin; K Mayer; A Meier-Hellmann; M Oppert; C Putensen; M Quintel; M Ragaller; R Rossaint; H Seifert; C Spies; F Stüber; N Weiler; A Weimann; K Werdan; T Welte
Journal:  Ger Med Sci       Date:  2010-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.